MktsMarkets

Citius Pharmaceuticals, Inc.
NASDAQ: CTXRKey statistics
CTXR News
Stories mentioning CTXR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,667 | 3,944 | ||||||
| Cost of Goods Sold | 329.00 | 789.00 | ||||||
| Gross Profit | 1,338 | 3,155 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 1,634 | 1,600 | 1,641 | 1,621 | 3,767 | 2,127 | 2,915 | 2,764 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 33,533 | 12,174 | 8,437 | 8,788 | 11,261 | 10,040 | 11,051 | 10,634 |
| Operating Income (Loss) | (32,195) | (9,019) | (8,437) | (8,788) | (11,261) | (10,040) | (11,051) | (10,634) |
| Interest Income | 54.00 | 45.00 | 53.00 | 21.00 | 13.00 | 23.00 | 117.00 | 205.00 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (28,341) | (9,130) | (8,479) | (8,940) | (11,247) | (10,017) | (10,934) | (10,429) |
| Tax Provision | (231.00) | 264.00 | 265.00 | 264.00 | 264.00 | 264.00 | 144.00 | 144.00 |
| Net Income (Loss) | (11,512) | (10,281) | (10,573) | |||||
| Earnings Per Share (Basic) | (0.95) | (0.38) | 0.00 | (0.80) | (1.27) | (1.30) | (1.61) | (1.57) |
| Earnings Per Share (Diluted) | (0.95) | (0.38) | 0.00 | (0.80) | (1.27) | (1.30) | (1.61) | (1.57) |
| Weighted Average Shares Outstanding (Basic) | 22,376 | 21,495 | 11,065 | 11,007 | 8,581 | 7,492 | 6,727 | 6,954 |
| Weighted Average Shares Outstanding (Diluted) | 22,376 | 21,495 | 11,065 | 11,007 | 8,581 | 7,492 | 6,727 | 6,954 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CTXR
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTXR. It last traded at $0.5500 (Nov 6, 2026, 9:30 AM ET), down 2.1% on the day. That gives Citius Pharmaceuticals a market capitalisation of $15.0M.
Over the past 52 weeks CTXR has traded between $0.3700 and $1.54.
Revenue for the quarter ended Mar 31, 2026 was $1.7M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | $1.7M | — |
| Dec 31, 2025 | $3.9M | — |
| Mar 31, 2025 | — | -$11.5M |
| Dec 31, 2024 | — | -$10.3M |
From Citius Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…